Skip to main content

Table 3 Associations between HCV positivity (anti-HCV antibodies and/or HCV RNA positive) and exposures to potential routes of HCV transmission in a sample of the Egyptian population

From: Viral transmission risk factors in an Egyptian population with high hepatitis C prevalence

Route of Transmission Exposure Response Exposure, N HCV Prevalence, % Unadjusted OR (95 % CI) Adjusted OR (95 % CI)a
Received PAT No 1408 23.1 Ref. Ref.
  Yes 305 60.2 1.62 (1.22, 2.16) 1.54 (1.14, 2.11)
Blood Transfusion No 1417 29.1 Ref. Ref.
  Yes 324 32.1 1.16 (0.87, 1.53) 1.31 (0.96, 1.79)
Blood Donation No 1252 31.4 Ref Ref.
  Yes 487 25.7 0.76 (0.59, 0.98) 0.76 (0.57, 1.02)
Diabetes Diagnosis No 1251 28.5 Ref. Ref.
  Yes 184 39.1 1.61 (1.16, 2.22) 1.23 (0.87, 1.76)
Number of Injections Less than 10 injections 116 24.1 Ref Ref.
  10 or more injections 1209 30.0 1.35 (0.87, 2.10) 1.24 (0.76, 2.02)
  Has injections frequently/continuously 92 31.5 1.45 (0.78, 2.67) 1.23, (0.63, 2.41)
  1. aAdjusted for sex, age group, birthplace, residence at time of interview, and education; ORs in bold indicate statistical significance
\